| Ms Lisa Marie Reichert, RN | |
|
90 N. 31st, Clinton, OK 73601 | |
| (580) 323-6021 | |
| (580) 323-5635 |
| Full Name | Ms Lisa Marie Reichert |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Psychiatric/mental Health, Adult |
| Location | 90 N. 31st, Clinton, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619070901 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0809X | Registered Nurse - Psychiatric/mental Health, Adult | R0077555 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lisa Marie Reichert, RN 1109 Dell Dr, Clinton, OK 73601-1821 Ph: (580) 323-8168 | Ms Lisa Marie Reichert, RN 90 N. 31st, Clinton, OK 73601 Ph: (580) 323-6021 |
News Archive
Intracellular pathogens adopt various strategies to circumvent the defences of the host cell and to proliferate intracellularly. One specific strategy is to target host organelles like the mitochondria. Mitochondria are well-defined cytoplasmic organelles, which take part in a variety of cellular metabolic functions.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves-despite the fact that knowing your genetic status may help catch the disease in its earliest stages.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
› Verified 9 days ago
Deonda Roberson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10321 N 2274 Rd, Clinton, OK 73601 Phone: 580-331-3300 Fax: 580-323-2579 | |
Kim S Elkin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 90th N. 31st, Clinton, OK 73601 Phone: 580-323-6021 Fax: 580-323-6021 | |
Mrs. Susan Bedwell, BSN, RN, PHN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10321 N 2274 Rd, Clinton, OK 73601 Phone: 580-331-3600 Fax: 580-323-2579 | |
Mrs. Amber Nicole Ellis, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 1701 S 4th St, Clinton, OK 73601 Phone: 405-376-9980 | |
Ms. Lydia Garvey, BS RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Rr 1 Box 3060, Clinton, OK 73601 Phone: 580-331-3471 | |
Carolyn Fletcher, BSN, RN, CDCES Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10321 N 2274 Rd, Clinton, OK 73601 Phone: 580-331-3300 Fax: 580-331-3552 | |
Stacy A Watson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 90 N 31st St, Clinton, OK 73601 Phone: 580-323-6021 |